SEQUVAX Trademark

Trademark Overview

On Friday, October 30, 2020, a trademark application was filed for SEQUVAX with the United States Patent and Trademark Office. The USPTO has given the SEQUVAX trademark a serial number of 90290010. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 29, 2024. This trademark is owned by Seqirus UK Limited. The SEQUVAX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

providing medical and scientific research information about the results of clinical trials for coronavirus and COVID-19 vaccines; providing medical and scientific research information in the field of coronavirus and COVID-19 vaccines and coronavirus and COVID-19 vaccine clinical trials
sequvax

General Information

Serial Number90290010
Word MarkSEQUVAX
Filing DateFriday, October 30, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 27, 2021

Trademark Statements

Goods and Servicesproviding medical and scientific research information about the results of clinical trials for coronavirus and COVID-19 vaccines; providing medical and scientific research information in the field of coronavirus and COVID-19 vaccines and coronavirus and COVID-19 vaccine clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 24, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSeqirus UK Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressMaidenhead, Berkshire SL68AA
GB
Party NameSeqirus UK Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressMaidenhead, Berkshire SL68AA
GB

Trademark Events

Event DateEvent Description
Tuesday, November 3, 2020NEW APPLICATION ENTERED
Wednesday, December 23, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 17, 2021ASSIGNED TO EXAMINER
Wednesday, March 24, 2021EXAMINERS AMENDMENT -WRITTEN
Wednesday, March 24, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, March 24, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 24, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, March 24, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 7, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 27, 2021PUBLISHED FOR OPPOSITION
Tuesday, April 27, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 22, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, November 12, 2021SOU TEAS EXTENSION RECEIVED
Friday, November 12, 2021SOU EXTENSION 1 FILED
Friday, November 12, 2021SOU EXTENSION 1 GRANTED
Tuesday, November 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 9, 2022SOU TEAS EXTENSION RECEIVED
Thursday, June 9, 2022SOU EXTENSION 2 FILED
Thursday, June 9, 2022SOU EXTENSION 2 GRANTED
Saturday, June 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 3, 2022SOU TEAS EXTENSION RECEIVED
Thursday, November 3, 2022SOU EXTENSION 3 FILED
Thursday, November 3, 2022SOU EXTENSION 3 GRANTED
Saturday, November 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 21, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, June 21, 2023SOU EXTENSION 4 FILED
Wednesday, June 21, 2023SOU EXTENSION 4 GRANTED
Friday, June 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 19, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, December 19, 2023SOU EXTENSION 5 FILED
Wednesday, January 10, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 29, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, July 29, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, January 10, 2024SOU EXTENSION 5 GRANTED

Related Keywords

sequvax covid coronavirus clinical trials providing information medical scientific research vaccines